Atlas Trials

A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI

Clinical trial NCT06704685 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06704685
Sponsor
Xiangya Hospital of Central South University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
ST-segment Elevation Myocardial Infarction (STEMI)
Start date
2024-12-01
Primary completion
2025-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.